News

Genesis Capital invests in Australian firm Crux Biolabs

Posted: 9 August 2022 Genesis Capital is partnering with existing management to expand Crux into new testing and clinical trial streams. Crux Biolabs, a leading Australian laboratory for vaccines, immunotherapies, immuno-oncology and infectious diseases, has announced a significant…

Neuren commences Phase 2 trials of NNZ-2591 in PMS and PTHS

Posted: 8 August 2022 Neuren Pharmaceuticals (ASX: NEU) today announced that its Phase 2 clinical trials of NNZ-2591 in children with each of Phelan-McDermid syndrome (PMS) and Pitt Hopkins syndrome (PTHS) are open for enrolment. The first subjects…

Burnet teams up with Monash and BioCurate to develop novel HIV antivirals

Posted: 4 August 2022 Burnet Institute, in collaboration with Monash Institute of Pharmaceutical Sciences (MIPS) has received Proof of Concept funding from BioCurate to develop next-generation human immunodeficiency virus (HIV) antivirals. The multi-disciplinary research team, led jointly by…

Breakthrough Victoria announces investment in Seer, powering global expansion

Posted: 25 July 2022 Breakthrough Victoria has announced recently its investment in Victorian medical technology group Seer Medical to support its plan to become a global leader in epilepsy home monitoring and management. Seer is globally renowned as…

NHMRC consultation on options to reach gender equity in the Investigator Grant scheme

Posted: 21 June 2022 The NHMRC has released a discussion paper presenting some options to reach gender equity in the Investigator Grant scheme. There will be a series of eight open forums held in Queensland, New South Wales,…

Acadia submits Rett Syndrome New Drug Application to the FDA 

Posted: 19 July 2022 Melbourne, Australia: Neuren Pharmaceuticals (ASX: NEU) is pleased to report that its US partner Acadia Pharmaceuticals (Nasdaq: ACAD) has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for…

ANDHealth extends partnership with Therapeutic Goods Administration to accelerate digital health regulatory adoption and commercialisation

Posted: July 18 2022 ANDHealth, Australia’s leading digital health commercialisation organisation, has announced the extension of its partnership with the Therapeutic Goods Administration (TGA) to support Australia’s fast-growing digital health sector.  The extended partnership will see TGA fund…

Australian Data Driven Healthcare Companies Can Win Gold At The Commonwealth Games

Posted: 15 July 2022 Data Driven Healthcare Trade & Investment Program 1 – 2 August 2022 During the Birmingham 2022 Commonwealth Games, the West Midlands Growth Company (WMGC) and the Department for International Trade (DIT) will deliver a…

Comprehensive Cancer PhD (CCPhD) Program is seeking industry professionals to connect with PhD students

Posted: 14 July 2022 Call out for Healthtech professionals! The Comprehensive Cancer PhD (CCPhD) Program is seeking around 10 Healthtech industry professionals to attend a career speed-dating session at their upcoming annual symposium. About the CCPhD Program The…

Advertising of Therapeutic Goods in Australia – Are your advertising campaigns compliant? – Stephens Lawyers & Consultants

Posted: 23 June 2022 Advertising compliance for therapeutic goods in Australia is complex, requiring one to remain up-to-date on a number of different advertising laws which are administered by different regulators.  This article provides a timely reminder that as…

First harvest at medicinal cannabis facility near Mildura in Victoria’s north-west

Posted: 16 June 2022 Key points: The first crop has been harvested from a medicinal cannabis facility built in a former fruit juice factory near Mildura Cann Group received approval to cultivate the crop at the $115 million…

Record 65,000 flu cases in May as experts warn 2022 flu resurgence redefines what it means to be ‘flu ready’

Posted: 14 June 2022   Infectious disease experts gathered at the BioMelbourne Network BioForum today to share concerns regarding influenza (flu) preparedness, emerging public health challenges and vaccine innovation.1  According to data captured by the National Notifiable Disease…

Home

News & opinion

Member Directory

Events